MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11916-021-00988-7

Медицинская библиотека · Current pain and headache reports · 2021

Update of Neuromodulation in Chronic Migraine.

Yuan Hsiangkuo, Chuang Tzu-Ying

СтатьяОбзорПеревод пока не подготовлен

Аннотация

PURPOSE OF REVIEW: Neuromodulation devices have become an attractive alternative to traditional pharmacotherapy for migraine, especially for patients intolerant to medication or who prefer non-pharmacological options. In the past decades, many studies demonstrated the efficacy of neuromodulation devices in patients with episodic migraine (EM). However, the benefit of these devices on chronic migraine (CM), which is typically more debilitating and refractory than EM, remains not well studied.

RECENT FINDINGS: We reviewed the literature within the last five years on using FDA-cleared and investigational devices for CM. There were eight randomized controlled trials and 15 open-label observational studies on ten neuromodulation devices. Neuromodulation is promising for use in CM, although efficacy varies among devices or individuals. Noninvasive devices are usually considered safe with minimal adverse events. However, stimulation protocol and methodology differ between studies. More well-designed studies adhering to the guideline may facilitate FDA clearance and better insurance coverage.

Для цитирования: Yuan Hsiangkuo, Chuang Tzu-Ying. Update of Neuromodulation in Chronic Migraine.. Current pain and headache reports. 2021. DOI: 10.1007/s11916-021-00988-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.